Summary. Twenty institutions/cooperative groups tabulat-ed second cancers among 12,411 patients diagnosed with Hodgkin's disease between 1960 and 1987, giving 82,850 person-years of observation. Overall, 631 second cancers were observed, as compared with 223.25 expected (observed (O) to expected (E) ratio 2.83, p<0.001) at least one year after the diagnosis of Hodgkin's disease. Second cancers were acute leukaemias (A_L) in 158 cases as compared with 5.75 expected (O/E = 27.48, p< 0.001), non-Hodgkin's lym-phomas (NHL) in 106 cases as compared with 3.34 expect-ed (O/E- 31.77, p< 0.001), and solid tumors (ST) in 367 cases as compared with 214.16 expected (O/E — 1.71, p<0.001), with no differences between males and ...
which relapsed after chemotherapy were treated with salvage radiotherapy (S-RT) with curative intent...
BACKGROUND: A retrospective analysis on HODGKIN'S DISEASE (HD) was finalized to see if changing the ...
The risk of a second malignancy was analyzed in 23 patients with Hodgkin's disease (HD) and 177 with...
Background: Long-term survivors of successfully treated Hodgkin’s disease (HD) are at risk for late ...
Abstract: Long-term survivors of Hodgkin’s lymphoma are at increased risk for a number of late compl...
Contains fulltext : 152700.pdf (publisher's version ) (Open Access)BACKGROUND: Sur...
Background: Numerous studies of treatment for Hodgkin's disease have demonstrated large increas...
Summary. Two cycles of MOPP (mechlorethamine, vincristine (Oncovin), procarbazine, prednisone) and r...
The risk of second primary cancer (SPC) was evaluated in 947 patients treated for Hodgkin's disease ...
The risk of second primary cancer (SPC) was evaluated in 947 patients treated for Hodgkin's disease ...
PURPOSE: We investigated the long-term risk of second primary malignancy after chemotherapy for Hodg...
Strasbourg Cedex BP 42, 67065, France Full list of author information is available at the end of the...
Abstract: Hodgkin’s lymphoma (HL) has a unique and distinct history, epidemiology, treatment, and bi...
Item does not contain fulltextBACKGROUND: Despite several investigations, second malignancy risks (S...
Background: Most studies of survivors of Hodgkin's disease have shown a low risk for subsequent...
which relapsed after chemotherapy were treated with salvage radiotherapy (S-RT) with curative intent...
BACKGROUND: A retrospective analysis on HODGKIN'S DISEASE (HD) was finalized to see if changing the ...
The risk of a second malignancy was analyzed in 23 patients with Hodgkin's disease (HD) and 177 with...
Background: Long-term survivors of successfully treated Hodgkin’s disease (HD) are at risk for late ...
Abstract: Long-term survivors of Hodgkin’s lymphoma are at increased risk for a number of late compl...
Contains fulltext : 152700.pdf (publisher's version ) (Open Access)BACKGROUND: Sur...
Background: Numerous studies of treatment for Hodgkin's disease have demonstrated large increas...
Summary. Two cycles of MOPP (mechlorethamine, vincristine (Oncovin), procarbazine, prednisone) and r...
The risk of second primary cancer (SPC) was evaluated in 947 patients treated for Hodgkin's disease ...
The risk of second primary cancer (SPC) was evaluated in 947 patients treated for Hodgkin's disease ...
PURPOSE: We investigated the long-term risk of second primary malignancy after chemotherapy for Hodg...
Strasbourg Cedex BP 42, 67065, France Full list of author information is available at the end of the...
Abstract: Hodgkin’s lymphoma (HL) has a unique and distinct history, epidemiology, treatment, and bi...
Item does not contain fulltextBACKGROUND: Despite several investigations, second malignancy risks (S...
Background: Most studies of survivors of Hodgkin's disease have shown a low risk for subsequent...
which relapsed after chemotherapy were treated with salvage radiotherapy (S-RT) with curative intent...
BACKGROUND: A retrospective analysis on HODGKIN'S DISEASE (HD) was finalized to see if changing the ...
The risk of a second malignancy was analyzed in 23 patients with Hodgkin's disease (HD) and 177 with...